IHH Healthcare Looks Attractive on Recent Share Price Weakness

Dow Jones09:08

0108 GMT - IHH Healthcare's recent share price weakness likely offers an attractive entry point, with earnings growth seen supported by more complex treatments, hospital expansions and Fortis-Gleneagles synergies, says Maybank IB analyst Nur Natasha Ariza in a note. Its focus on higher-value treatments and day-care services should also support growth beyond bed additions, she says. IHH's core net profit is expected to grow 18% annually over 2025-2028, faster than its 11% annual growth over 2016-2025, she reckons. Legal developments in its India operations provide little basis to revise earnings forecasts, in the analyst's view. Maybank maintains a buy rating on IHH and keeps its target price at 11.20 ringgit. Shares are unchanged at 7.90 ringgit.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment